Thinking about the future after participating in the 100,000 Genomes Project

Helping others in the future

People were glad of the opportunity to help improve medical knowledge about the causes of rare diseases and cancer and hoped it would lead to new medical developments in the future. Linda says, ‘It gives you a really good sense of satisfaction,’ and Edward talked about the ‘thrill of helping out’. Jenny was ‘quite excited’ about ‘the potential in the future to use that sort of information once things have developed even more’.

Mark and Julie hope that the results from the project are well publicised so people are aware of the positive outcomes and are encouraged to participate in other projects in future.

Age at interview 50

Age at diagnosis 52

View profile

Richard sees participation as something that will help future generations, rather than having a direct benefit to him. He feels that anybody given the chance to take part should see it as a duty.

Age at interview 73

Gender Male

Age at diagnosis 73

View profile

The data that participants and their families provide for the 100,000 Genomes Project will be kept for many years and used by the project both now and in the future. Birgit says she sees it as a long term project for researchers to ‘dip in and out’ of. People mostly trusted that their data would be kept securely in the future, although some wondered about whether data protection policies might change and what new technologies might mean for data use.

Lucy Y wanted to know more about how the data would be stored, and was concerned about the possibility of it being used for the wrong reasons’s in the future.

Age at interview 39

Gender Female

View profile

Emma and her husband said that if there were any future changes to the project which they weren’t happy with, they knew they could opt out at any point.

What project might mean for them personally in future

Several people shared their thoughts about what the project might mean in the future for them personally.

As well as providing information about a person’s cancer or rare condition, the project can provide information about whether a person is at risk of developing some specific inherited life threatening conditions during their lifetime that are not connected to the cancer or rare condition that brought them to the project. Genomics England provides a list of these conditions (which changes as medical knowledge advances) on the results page of their website (see our Resources page). These conditions can often be treated or reduced through NHS treatments.

Jenny thought it was good that it is only treatable conditions that she would be told about.

Age at interview 23

Gender Female

View profile

Nick would rather know if he is predisposed to develop a condition, even if it is untreatable. He was told it would take about a year to process each sample.

Age at interview 52

Gender Male

View profile

Those who had consented to this talked about the benefits of finding out. Stuart, whose father has myeloma, says, ‘If I get some genetic pre-warning of a condition that I might be exposed to in the future then whilst it’s a bit scary I’d rather have that knowledge because then potentially you can treat it.’

Birgit wasn’t sure she would want to know about any secondary findings.

Age at interview 41

Gender Female

Age at diagnosis 41

View profile

Aileen says she is a rather know about it kind of person.

Age at interview 57

Gender Female

Age at diagnosis 56

View profile

When Heather and Julie were told they could get results about risk of future life threatening illnesses they felt that was a huge benefit to participating. But they understand why some people might not want to know.

Emma was sure she wanted to know if she was at risk of developing health conditions, such as cancer, in the future. Her husband found it a harder decision to make.

Age at interview 40

Gender Female

View profile

A few had concerns about the implications of discovering more about their health and health risks. Some considered whether they would tell extended family if there were findings that might affect them. Others were concerned about the practical implications of any results for them, such as how it might affect future insurance premiums.

Although Mark and Julie know there is an agreement that they don’t have to disclose the results to insurance companies, except when taking out new policies, they worry this might change in the future.

Age at interview 50

Age at diagnosis 52

View profile

What it would mean for future generations of their family

People we spoke to said that one of the reasons they were taking part in the project was to find out if future generations might be at higher risk of developing a health condition. Victoria, who has breast cancer, said, ‘It might not help me but it could possibly help my granddaughters I’m trying to protect them.’ Pam said that with two daughters, two son-in-laws, seven grandchildren and three great grandchildren, she hoped that by taking part this would ‘help their health in the future’.

Lucy Y is the only person in her family who has symptoms of EDS but she thinks the results could tell them if her family members or their children might be at risk.

Age at interview 39

Gender Female

View profile

By knowing if they were at risk of developing a health condition, people said future generations could take preventative measures, such as taking part in screening. Nicola said that as her cancer was gynaecological, any results could have implications for her daughter, nieces and sister.

Rebecca has breast cancer and talks about the benefits of her daughter being able to be screened for the breast cancer gene.

Age at interview 49

Gender Female

Age at diagnosis 48

View profile